65,437 trials
Stroke
Primary: Box and Blocks Test (BBT) — 5.7; 8.8 blocks
Acute Infectious Conjunctivitis (Disorder)
Primary: Complete Clinical Resolution — 9; 0 Participants
Child Abuse · Child Neglect
Primary: Child Welfare Services Removal From Birth Parent Home — 12; 19 Participants — p=.159
Hypercholesterolemia
Primary: Number of Participants Achieving Individual LDL-C Target (<55 mg/dL or <70 mg/dL) — 752; 266 Participants — p=<0.0001
Geographic Atrophy · Age-Related Macular Degeneration
Primary: Number of Participants With Adverse Events (AEs) — 50; 49; 129 Participants
Asthma
Primary: FEV1 AUC0-12h Normalised by Time on Day 42 — 2.327; 2.332; 2.272; 2.296 liters — p=<0.001
Parkinson's Disease
Primary: MRI-derived Free Water (FW) Levels — 7.9; -3.8; 1.5 % change
Gastric Cancer
Primary: The Incidence of Adverse Drug Reactions (ADRs) — 4; 0 Participants
Cochlear Hearing Loss
Primary: Freiburger Monosyllabic Word Recognition Score in Quiet — 50.6 Percent correct in the Freiburger Monosy
Sleep-Disordered Breathing · Sleep Architecture
Primary: To Evaluate the Ability of the Belun Ring Pulse Oximeter to Gauge the Apnea-Hypopnea Index (AHI) — -1.0 events per hour
Ureteral Stones · Ureteroscopic Lithotripsy
Primary: Change in STAI-TX1 Score (Postoperative - Preoperative) — 1.35; 5.05 Scores on a scale
Pain · Opioid Use
Primary: Count of Referrals to Non-opioid Care — 3.075; 3.61 Count of referrals — p=0.213
Prostate Cancer
Primary: Number of Participants With Biochemical Failure — 12; 52 Participants
Therapeutic Adherence · Nurse-Patient Relations · Sleep Disorder
Primary: Visual Analogue Scale — 60.6; 54.7 score on a scale — p=0.225
Endometriosis
Primary: Pain Measurement - Acyclic Pain — 7.1; 7.0; 4.7; 6.7 VAS pain score — p=0.02